Granules India Q4 results preview: Paracetamol, Ibuprofen maker's net profit likely to grow 26%, margin may improve by 130 bps
Granules India Q4 results preview: Granules India, which manufactures painkiller drug Paracetamol and anti-inflammatory drug Ibuprofen, will report its Q4 results on May 16. Will Granules India also announce a dividend?
Granules India Q4 results preview: Hyderabad-based pharma company Granules India, which makes painkiller drug Paracetamol, is all set to report its financial results for the quarter ended March 2023 on Tuesday, May 16. Analysts expect the drug maker's active pharmaceutical ingredients (API) and finished dosage formulation (FDF) segments to support its overall growth.
According to Zee Business research, Granules India — which also manufactures anti-inflammatory drug Ibuprofen — is likely to report a net profit of Rs 140 crore for the January-March period, which translates to year-on-year growth of more than 26 per cent.
The analysts peg the company's revenue growth at 10 per cent to Rs 1,137 crore.
Granules India is estimated to report an 18 per cent increase in earnings before interest, taxes, depreciation and ammortisation (EBITDA) to Rs 227 crore, according to the research.
Its margin is likely to improve by 130 basis points (1.3 percentage points) to 20 per cent compared with the year-ago period.
Investors will closely track the company's performance in its core molecules unit. The company earns the lion's share of its revenue from core molecules such as Paracetamol, Metformin and Guaifenesin. They will also look out for any clarity on the company's capital expenditure (capex) related to Greenko.
Granules India is in a strategic partnership with renewable energy group Greenko to develop integrated green pharma zones.
Granules India shares: Historical performance
Granules India shares lost 8.8 per cent of their value in the March quarter, a period in which the Nifty 50 index declined 4.1 per cent.
The stock finished 2022 with a loss of 19.8 per cent, worse than a five per cent fall in the headline index.
Will Granules India also announce a dividend on May 16?
Granules India dividend history
Granules India has a history of rewarding its shareholders regularly, having paid a string of payouts over the past few years.
In the past five years, the company has paid 16 dividends.
Dividend announcement | Ex-dividend date | Dividend type | Dividend amount (in rupees) |
May 2022 | July 7, 2022 | Final | 75 |
February 2022 | February 17, 2022 | Interim | 25 |
November 2021 | November 24, 2021 | Interim | 25 |
July 2021 | August 5, 2021 | Interim | 25 |
May 2021 | July 28, 2021 | Final | 75 |
January 2021 | February 8, 2021 | Interim | 25 |
October 2020 | October 28, 2020 | Interim | 25 |
June 2020 | August 5, 2020 | Final | 25 |
July 2020 | July 28, 2020 | Interim | 25 |
January 2020 | January 30, 2020 | Interim | 25 |
October 2019 | October 31, 2019 | Interim | 25 |
May 2019 | August 21, 2019 | Final | 25 |
July 2019 | August 8, 2019 | Interim | 25 |
January 2019 | February 7, 2019 | Interim | 25 |
October 2018 | November 6, 2018 | Interim | 25 |
May 2018 | August 29, 2018 | Final | 25 |
Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets
Power of Compounding: How long it will take to build Rs 5 crore corpus with Rs 5,000, Rs 10,000 and Rs 15,000 monthly investments?
SCSS vs FD: Which guaranteed return scheme will give you more quarterly income on Rs 20,00,000 investment?
Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations
08:46 PM IST